CDC expects new Covid vaccines from Pfizer, Moderna and Novavax to be available in mid-September
Publishing timestamp: 2023-08-25 05:06:02
Summary
The Centers for Disease Control and Prevention (CDC) expects updated Covid vaccines from Pfizer, Moderna, and Novavax to be available to the public in mid-September. These vaccines are designed to target the omicron subvariant XBB.1.5. The vaccines still need approvals from the Food and Drug Administration (FDA) and CDC, and eligibility guidelines will be set. The arrival of updated vaccines offers reassurance as the U.S. sees a slight uptick in Covid cases and hospitalizations, although metrics remain below last year's summer peak. The vaccines are also expected to protect against the newer strain EG.5, but it is unclear how well they will protect against another new omicron strain called BA.2.86. However, the vaccines are likely to protect against severe outcomes from catching the Covid virus.
Sentiment: NEUTRAL
Keywords: business news, business, pharmaceuticals, novavax inc, health care industry, moderna inc, biotechnology, pfizer inc, biotech and pharmaceuticals,